Announces

School of Medicine Announces 2022 Nathan Deal Scholars

School of Medicine Announces 2022 Nathan Deal Scholars

MACON/SAVANNAH/COLUMBUS – Mercer University School of Medicine (MUSM) recently announced 12 new Nathan Deal Scholars for the 2022-23 academic year. Fellows are selected based on their strong ties to rural Georgia, character, leadership qualities, community involvement, and likelihood of serving in rural, underserved Georgia once their fellowship obligations are met. fulfilled. They will receive 85-100% …

School of Medicine Announces 2022 Nathan Deal Scholars Read More »

Baylor Athletics announces fundraising effort to support mental health initiatives - Baylor University Athletics

Baylor Athletics announces fundraising effort to support mental health initiatives – Baylor University Athletics

WACO, TX – Baylor University today announced the public launch of an effort to create philanthropic support focused on growing mental health services for Baylor student-athletes. The launch comes with a donation from Jarred and Kay Nan Sloan of Houston supporting Baylor Athletics and Athletics Mental Health Services (AMHS) funding, which ensures Baylor student-athletes have …

Baylor Athletics announces fundraising effort to support mental health initiatives – Baylor University Athletics Read More »

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced positive interim clinical results from an ongoing Phase 2 study of its lead clinical development candidate, pegsitacianine, for the detection of residual disease after cytoreductive surgery. (CRS). Study results were presented by Patrick Wagner, MD, Department of Surgical Oncology, Allegheny Health Network Cancer Institute, during an oral presentation …

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis Read More »

Biden Administration Announces $8 Billion Commitments to Address Hunger, Nutrition and Health Issues

Biden Administration Announces $8 Billion Commitments to Address Hunger, Nutrition and Health Issues

Today, President Biden and key senior officials hosted the White House Conference on Hunger, Nutrition and Health. The goal of the conference is simple: to address issues related to food insecurity and diet-related chronic diseases that affect millions of Americans each year. The White House highlighted how nearly $8 billion in private and public sector …

Biden Administration Announces $8 Billion Commitments to Address Hunger, Nutrition and Health Issues Read More »

Zerodha co-founder Nithin Kamath starts health challenge for employees (MINT_PRINT)

Zerodha boss issues fitness challenge to employees; announces a one month bonus

Financial services firm Zerodha, which encouraged its employees to focus on their health during the Covid 2020 pandemic, has now made fitness the norm. In the latest initiative, the head of Zerodha, Nithin Kamath, has issued a new health challenge to employees to make time for training/exercise/sports activities. Zerodha employees would have the ability to …

Zerodha boss issues fitness challenge to employees; announces a one month bonus Read More »

CerraCap Cares Announces Investment in Cuentame, a Founder-Led Startup Poised to Become the First Mental Health Unicorn

CerraCap Cares Announces Investment in Cuentame, a Founder-Led Startup Poised to Become the First Mental Health Unicorn

CerraCap Cares announces its investment in Cuentame, whose mission is to remove all barriers to mental health, by providing organizations with the right tools to create a highly integrated and mentally healthy work environment. COSTA MESA, Calif., September 23, 2022 /PRNewswire/ — CerraCap Cares, a women-led impact fund, recently invested in Cuentame which is poised …

CerraCap Cares Announces Investment in Cuentame, a Founder-Led Startup Poised to Become the First Mental Health Unicorn Read More »

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy

Members Bradley BernsteinMD, Ph.D., Paula Canondoctorate, howard changMD, Ph.D., and Ahmad (Mo) KhalilPh.D., will guide the advancement of the company’s epigenetic editing platform and key programs Scientific Advisors Join Chroma Founders, Luke Gilbertdoctorate, Keith Young MD., Ph.D., David Liudoctorate, Angelo Lombardodoctorate, Luigi NaldiniMD, Ph.D., and jonathan weismanPh.D., expanding the company’s world-class team of genomic medicine …

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy Read More »

Attorney General Brnovich announces grants to 11 organizations to address the opioid crisis - State of Reform

Attorney General Brnovich announces grants to 11 organizations to address the opioid crisis – State of Reform

Attorney General Mark Brnovich today announced [Sept. 15th] the Arizona Attorney General’s Office (AGO) has awarded $6 million in grants to eleven organizations across the state to address the opioid crisis. The funding will be used to support opioid abuse and underlying mental health issues for more than 21,000 children, pregnant women and mothers, veterans, …

Attorney General Brnovich announces grants to 11 organizations to address the opioid crisis – State of Reform Read More »

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

The ROSALIA study met the primary endpoints, confirming that the proposed biosimilar denosumab matches the reference product in terms of pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity in postmenopausal women with osteoporosis Osteoporosis is responsible for 8.9 million bone fractures a year, including debilitating hip fractures – a number that is expected to rise dramatically over …

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab Read More »